Chinese Biotechs' Foray Into mRNA Enters New Chapter With $100m Everest Deal

 
• By Dexter Jie Yan
  
Chinese biotechs foray into mRNA
Everest the latest Chinese biotech to leap into mRNA fray • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia